Veerle Compernolle

8.6k total citations · 1 hit paper
85 papers, 2.4k citations indexed

About

Veerle Compernolle is a scholar working on Hematology, Management of Technology and Innovation and Biochemistry. According to data from OpenAlex, Veerle Compernolle has authored 85 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 33 papers in Management of Technology and Innovation and 27 papers in Biochemistry. Recurrent topics in Veerle Compernolle's work include Blood donation and transfusion practices (33 papers), Blood transfusion and management (27 papers) and Platelet Disorders and Treatments (18 papers). Veerle Compernolle is often cited by papers focused on Blood donation and transfusion practices (33 papers), Blood transfusion and management (27 papers) and Platelet Disorders and Treatments (18 papers). Veerle Compernolle collaborates with scholars based in Belgium, China and Netherlands. Veerle Compernolle's co-authors include Peter Carmeliet, Philippe Vandekerckhove, Marc Tjwa, Koen Brusselmans, Hendrik B. Feys, Désiré Collen, Lieve Moons, Mieke Dewerchin, Emmy De Buck and Michael S. Wiesener and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Veerle Compernolle

83 papers receiving 2.4k citations

Hit Papers

Loss of HIF-2α and inhibition of VEGF impair fetal lung m... 2002 2026 2010 2018 2002 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice
    2002 590 citations Veerle Compernolle, Koen Brusselmans et al. Nature Medicine profile →

Peers

Veerle Compernolle
Bruce S. Sachais United States
Richard L. Marquet Netherlands
JN George United States
Harvey R. Gralnick United States
Seiji Madoiwa Japan
J W Adamson United States
Michele Maria Luchetti Italy
Leonard Bell United States
R Bach United States
Mario Motta Italy
Bruce S. Sachais United States
Veerle Compernolle
Citations per year, relative to Veerle Compernolle Veerle Compernolle (= 1×) peers Bruce S. Sachais

Countries citing papers authored by Veerle Compernolle

Since Specialization
Citations

This map shows the geographic impact of Veerle Compernolle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veerle Compernolle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veerle Compernolle more than expected).

Fields of papers citing papers by Veerle Compernolle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veerle Compernolle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veerle Compernolle. The network helps show where Veerle Compernolle may publish in the future.

Co-authorship network of co-authors of Veerle Compernolle

This figure shows the co-authorship network connecting the top 25 collaborators of Veerle Compernolle. A scholar is included among the top collaborators of Veerle Compernolle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veerle Compernolle. Veerle Compernolle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Compernolle, Veerle, et al.. (2024). Differential composition and yield of leukocytes isolated from various blood component leukoreduction filters. Journal of Immunological Methods. 533. 113733–113733.
2.
Hurk, Katja van den, Susan Mikkelsen, Emmy De Buck, et al.. (2024). Balancing Donor Health and Plasma Collection: A Systematic Review of the Impact of Plasmapheresis Frequency. Transfusion Medicine Reviews. 38(4). 150851–150851. 1 indexed citations
3.
Wouters, Elise, Rana Abdelnabi, Dirk Jochmans, et al.. (2023). Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters. EBioMedicine. 92. 104597–104597. 3 indexed citations
4.
Remoortel, Hans Van, Katja van den Hurk, Veerle Compernolle, et al.. (2023). Very‐high frequency plasmapheresis and donor health–absence of evidence is not equal to evidence of absence. Transfusion. 63(12). 2358–2361. 3 indexed citations
5.
Toivonen, Jarkko, Veerle Compernolle, Surendra Karki, et al.. (2023). An international comparison of haemoglobin deferral prediction models for blood banking. Vox Sanguinis. 118(6). 430–439. 5 indexed citations
6.
7.
Buck, Emmy De, et al.. (2023). Does cold storage of blood before transfusion prevent the transmission of syphilis? A systematic review and meta‐analysis. Vox Sanguinis. 119(3). 219–231. 2 indexed citations
8.
Buck, Emmy De, Susan Mikkelsen, Pierre Tiberghien, et al.. (2023). Safety and protection of plasma donors: A scoping review and evidence gap map. Vox Sanguinis. 119(2). 110–120. 5 indexed citations
9.
O’Brien, Sheila F., Femmeke J. Prinsze, Whitney R. Steele, et al.. (2022). Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study. Vox Sanguinis. 117(9). 1085–1089. 2 indexed citations
10.
Avau, Bert, Hans Van Remoortel, Jorien Laermans, et al.. (2021). Lack of Cost-Effectiveness of Preoperative Erythropoiesis-Stimulating Agents and/or Iron Therapy in Anaemic, Elective Surgery Patients: A Systematic Review and Updated Analysis. PharmacoEconomics. 39(10). 1123–1139. 4 indexed citations
11.
12.
Compernolle, Veerle, et al.. (2020). Platelet Biochemistry and Morphology after Cryopreservation. International Journal of Molecular Sciences. 21(3). 935–935. 19 indexed citations
13.
14.
Compernolle, Veerle, et al.. (2019). Impact of cold storage on platelets treated with Intercept pathogen inactivation. Transfusion. 59(8). 2662–2671. 28 indexed citations
15.
Sicot, Géraldine, et al.. (2019). A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device. Vox Sanguinis. 114(4). 330–339. 10 indexed citations
16.
Feys, Hendrik B., et al.. (2018). Biomolecular Consequences of Platelet Pathogen Inactivation Methods. Transfusion Medicine Reviews. 33(1). 29–34. 30 indexed citations
17.
Remoortel, Hans Van, Emmy De Buck, Tessa Dieltjens, et al.. (2015). Methodologic quality assessment of red blood cell transfusion guidelines and the evidence base of more restrictive transfusion thresholds. Transfusion. 56(2). 472–480. 11 indexed citations
18.
Dahl, Karen D. Cowden, Benjamin H. Fryer, Fiona Mack, et al.. (2005). Hypoxia-Inducible Factors 1α and 2α Regulate Trophoblast Differentiation. Molecular and Cellular Biology. 25(23). 10479–10491. 185 indexed citations
19.
Brusselmans, Koen, Veerle Compernolle, Marc Tjwa, et al.. (2003). Heterozygous deficiency of hypoxia-inducible factor–2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. Journal of Clinical Investigation. 111(10). 1519–1527. 256 indexed citations
20.
Compernolle, Veerle, Koen Brusselmans, Till Acker, et al.. (2002). Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nature Medicine. 8(7). 702–710. 590 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce S. Sachais Breakdown of academic impact, for papers by Richard L. Marquet Breakdown of academic impact, for papers by JN George Breakdown of academic impact, for papers by Harvey R. Gralnick Breakdown of academic impact, for papers by Seiji Madoiwa Breakdown of academic impact, for papers by J W Adamson Breakdown of academic impact, for papers by Michele Maria Luchetti Breakdown of academic impact, for papers by Leonard Bell Breakdown of academic impact, for papers by R Bach Breakdown of academic impact, for papers by Mario Motta
Rankless by CCL
2026